Tag Archives: Coronavirus

Inquiry Begins Into AstraZeneca’s Coronavirus Vaccine Trial

Scientists on Wednesday praised the decision by AstraZeneca to suspend its late-stage coronavirus vaccine trials and begin a safety review after learning that a participant had developed a serious neurological condition. Dr. Francis Collins, the director of the National Institutes of Health, testifying at a Senate hearing on Wednesday, said the step “ought to be… Read More »

AstraZeneca begins final trials of Oxford University coronavirus vaccine enrolling 50,000 people

AstraZeneca begins final trials of Oxford University coronavirus vaccine enrolling 50,000 people worldwide and 30,000 in the US as company signs £15million manufacturing deal Thousands volunteers already being injected with jab in UK, Brazil, South Africa Preliminary data from phase 3 trials expected ‘soon’, said lead jab researcher  Developers say they hope to deliver the… Read More »